Kerrisdale Capital Management has raised an estimate of $100 million from investors. The new co-investment fund by Kerrisdale is the first of its kind in the investment market. The firm plans to use the money it has raised to short the stock of a company that it will be unveiling soon. According to Sahm Adrangi who communicated via email, the firm raised a meaningful amount of capital within a short period. Shane Wilson and Sahm Adrangi are working on a website, and video as a campaigning tool to convince investors. From an anonymous source, the target company is to be unveiled in Mid-May and the fund is already buying stock to establish the position of the company.
Kerrisdale Capital Management has a history of betting against companies then taking its case public. Its main hedge fund that bets for and against company stocks has an average annual return of 28% in the last five years. Kerrisdale Capital Management shares research on different industries and companies but recently, Sahm Adrangi has focused more of his effort in the sectors in which the company has developed expertise.
One of its areas of focus is the biotechnology sector and the firm has published research on a number of development stage firms like Zafgen and Bavarian Nordic. Sahm Adrangi has also interacted with Lindsay Corporation in an attempt to optimize the cash deployment of the company and its capital allocation policies. His leadership has seen the company grow steadily of the years.
Sahm Adrangi is the chief investment officer and founder of Kerrisdale Capital Management. He has been responsible for the development of the firm since 2009 when he launched the company with less than $1 million. As of July 2017, Kerrisdale Capital Management manages $150 million.
Sahm Adrangi studied Bachelor of Arts in Economics at Yale University. He began his financial career at Deutsche Bank. He also worked at Longrace Management. Sahm Adrangi is a speaker at several conferences that includes the Value Investing Conference, Traders 4 a Cause and Sohn Conference among others. He has been featured in many publications that include the New York Times, Businessweek, and the Washington Post.